Skip to main content
Caplight Logo









Synartro AB

Synartro AB

Private
UppsalaHealthcare & Life Scienceshttps://synartro.com/

Last Round

VC Round

Oct 9, 2024

Total Funding Raised

$6.36M

Company Overview

Synartro AB is a life science company that develops local injection treatments for osteoarthritis by combining proprietary slow-release technology with existing proven drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug deliverydrug delivery platforminflammatory disease treatmentbiopharmaclinical-stage biotechhyaluronandrug candidatetherapeutic developmentpreclinical developmentclinical trialsdrug licensinggmp manufacturingpharma r&ddrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synartro AB Comparables

Compare Synartro AB with similar companies based on industry and business-model similarity.

Synartro AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eupraxia Pharmaceuticals Inc.
78%
Relevium Medical
76%
TLC BioSciences Corp.
75%

Synartro AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 9, 2024
Convertible DebtOct 9, 2024
Series AOct 25, 2021
SeedOct 2, 2020

Key People

Founding team and executive leadership

Magnus Hurst

CEO (acting), CFO

Executive Team

Synartro AB Investors

Notable investors and investment history

Synartro AB investors
InvestorRounds
ScietyConvertible Debt, VC Round, Series A, Seed
Linc ABConvertible Debt, Seed, VC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2024

    $1.35M round led by Linc AB and Sciety

  • Oct 9, 2024

    $529K raised from Linc AB and Sciety

Synartro AB Filings

Explore SEC and related filing metadata, where available.

Synartro AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Synartro AB's valuation, stock price, and market status.

Is Synartro AB a public or private company?

Synartro AB is a private company.

What is the current stock price of Synartro AB?

Synartro AB is a private company with no public stock price. No recent secondary market data is available.

How much is Synartro AB worth (valuation)?

Valuation information for Synartro AB is not publicly available.

Can I buy Synartro AB stock?

Synartro AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Synartro AB's last funding round?

Synartro AB's most recent funding round was VC Round on October 9, 2024.

Who are the main investors in Synartro AB?

Key investors in Synartro AB include Sciety, Linc AB.

Will Synartro AB IPO soon?

No public IPO plans have been announced for Synartro AB.

How can I track Synartro AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synartro AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUppsala
Employee Range4
Year Founded2011
Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?